Nitazoxanide/azithromycin combination for COVID-19: A suggested new protocol for early management-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nitazoxanide/azithromycin combination for COVID-19: A suggested new protocol for early management

Published:2020-07 Issue: Volume:157 Page:104874
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Kelleni Mina T.^ORCID

Publisher

Elsevier BV

Subject

Pharmacology

Reference24 articles.

1. Impact of ivermectin administered for scabies treatment on the prevalence of head lice in Atoifi, Solomon Islands;Coscione;PLoS Negl. Trop. Dis.,2018

2. The binding interactions of the macrolide endectocide ivermectin with the antibiotics ampicillin, chloramphenicol and tetracycline HCL;Kandeel;Indian J. Pharm. Sci.,2012

3. Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial;Smit;Lancet Infect. Dis.,2018

4. The FDA-approved drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro;Caly;Antiviral Res.,2020

5. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection;Soboslay;Clin. Exp. Immunol.,1994

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 mortality paradox (United States vs Africa): Mass vaccination vs early treatment;World Journal of Experimental Medicine;2024-03-20

2. Repurposing metformin to manage idiopathic or long COVID Tinnitus: self-report adopting a pathophysiological and pharmacological approach;Inflammopharmacology;2024-01-31

3. Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update;Clinical Pathology;2024-01

4. What are the current anti-COVID-19 drugs? From traditional to smart molecular mechanisms;Virology Journal;2023-10-24

5. The African Kelleni’s roadmap using nitazoxanide and broad-spectrum antimicrobials to abort returning to COVID-19 square one;Inflammopharmacology;2023-06-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3